RE:RE:RE:RE:Can you name one needle moving acquisition ...True ... this is a big deal and you need to let it run its course. The ink hasn't even dried on the deal and you're freaking out about how bad it is.
I was thinking more along the lines of individual drug licenses - all small. That will likely continue.